Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer
Authors
Keywords
Scopoletin, NSCLC, Network pharmacology, Mechanism of action, Molecular docking, In vitro
Journal
LIFE SCIENCES
Volume -, Issue -, Pages 119105
Publisher
Elsevier BV
Online
2021-01-24
DOI
10.1016/j.lfs.2021.119105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptogenic flower buds exert cancer preventive effects by enhancing the SCFA-producers, strengthening the epithelial tight junction complex and immune responses
- (2020) Wenrui Xia et al. PHARMACOLOGICAL RESEARCH
- Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
- (2019) Pietro Paolo Vitiello et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lung Cancer
- (2019) Faria Nasim et al. MEDICAL CLINICS OF NORTH AMERICA
- Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
- (2018) J Remon et al. ANNALS OF ONCOLOGY
- Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity
- (2018) Yu Xia et al. BIOMEDICINE & PHARMACOTHERAPY
- Cryptotanshinone Induces Cell Cycle Arrest and Apoptosis of NSCLC Cells through the PI3K/Akt/GSK-3β Pathway
- (2018) Sang-A Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- How to unleash mitochondrial apoptotic blockades to kill cancers?
- (2017) Jing Deng Acta Pharmaceutica Sinica B
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- A targeted proteomics approach to the quantitative analysis of ERK/Bcl-2-mediated anti-apoptosis and multi-drug resistance in breast cancer
- (2016) Ting Yang et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs
- (2016) Jérôme Fortin et al. CANCER CELL
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- Programmed Cell Death in Animal Development and Disease
- (2011) Yaron Fuchs et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started